[Targeted therapy of pulmonary arterial hypertension (PAH)]. [electronic resource]
- Deutsche medizinische Wochenschrift (1946) Dec 2014
- S142-50 p. digital
Publication Type: Journal Article; Review
1439-4413
10.1055/s-0034-1387489 doi
Adult Antihypertensive Agents--adverse effects Combined Modality Therapy Cooperative Behavior Drug Approval Drug Therapy, Combination Endothelin Receptor Antagonists--adverse effects Evidence-Based Medicine Humans Hypertension, Pulmonary--diagnosis Interdisciplinary Communication Molecular Targeted Therapy--methods Phosphodiesterase 5 Inhibitors--adverse effects Pyrazoles--adverse effects Pyrimidines--adverse effects Randomized Controlled Trials as Topic Survival Rate Treatment Outcome